Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
J. R. Mackey, T. Pieńkowski, J. Crown, S. Sadeghi, M. Martin, A. Chan, M. Saleh, S. Sehdev, L. Provencher, V. Semiglazov, M. F. Press, G. Sauter, M. Lindsay, V. Houé, M. Buyse, P. Drevot, S. Hitier, S. Bensfia, W. Eiermann
Research output: Contribution to journal › Article › peer-review
47Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial'. Together they form a unique fingerprint.